BioBreak brings biotech, pharma, medtech, diagnostic and venture capital executives together to foster a stronger environment for the life sciences.
Joined April 2011
- Tweets152
- Following306
- Followers285
- Likes333
BioBreak retweeted
What are the three basic forces that shaped the financial landscape for #biotech in 2021 and why will they drive the market in 2022? @LocustWalkPtrs's @GeoffMeyerson provides his insights to @STAT’s @sheridan_kate.
Click here to read the full article: statnews.com/2021/12/29/3-bi…
BioBreak retweeted
Join us for a panel "Has Biotech Peaked Nov 16 at 1pm ET. The discussion will be moderated by @GeoffMeyerson of @LocustWalkPtrs joined by Katherine Breedis of @DanforthAdvisor, Rachael Bushey of @troutmanpepper, & Anurag Jindal of @SVBLeerink.
Register: us06web.zoom.us/webinar/regi…
BioBreak retweeted
Did you miss last week's panel "Why So Many Biopharma M&A Transactions Start Out as Aspirational Licensing Deals"?
Click here to watch: youtube.com/watch?v=4FO2CneW…
#lifesciences #biotech #biopharma #thoughtleadership #mergersandacquisitions
BioBreak retweeted
#Register today! On the heels of the publication of our recent white paper examining biotech M&A transactions, we are hosting a panel "Why So Many Biopharma M&A Transactions Start Out as Aspirational Licensing Deals" on Sept 30 at 1pm ET.
Register: lnkd.in/di83BKha
BioBreak retweeted
Join us for a panel "Why So Many Biopharma M&A Transactions Start Out as Aspirational Licensing Deals" on Sept 30 at 1pm ET.
Leading the discussion will be experts from @LocustWalkPtrs, @FogPharma, and @GoldmanSachs.
Register here: lnkd.in/di83BKha
BioBreak retweeted
Watch last week's panel discussion, "What Biopharma Should Expect From The Public Markets In 2H 2021". Hear panelists' positive outlooks and their cautions moving into 2022.
Click here to watch the recording: lnkd.in/eu6a2eJK
BioBreak retweeted
Join us for a panel on Aug 11 at 12pm ET entitled "What Biopharma Should Expect From The Public Markets In 2H 2021". Executives from @LocustWalkPtrs, @goodwinlaw, & Delphi Ventures will share their market forecasts for the second half of 2021.
Register: lnkd.in/e8mzbkG
BioBreak retweeted
#Eurpean M&A activity in Q2 is in line with previous years but 3x higher than a slow Q1 2021. This slight rebound is due to five completed transactions, increasing the total deal value back towards levels comparable to Q3 and Q4 2020.
#lifesciences #marketconditions
BioBreak retweeted
What is the good, the bad, & the ugly of being a first-time #biopharma CEO? Tune into a panel next week on June 16 moderated live by @RfwrightLSL interviewing first-time CEOs @RogerCrystalMD, Frank Lee, and @IvanaLiebisch. Join the conversation! bit.ly/34hTkoF
BioBreak retweeted
Our Chief People Officer Kelly Schick is looking forward to participating in a CEO Forum hosted by @BioBreakOrg on June 23 at 5pm ET and discussing post-pandemic talent management strategies. Learn more about the event here: lnkd.in/eQFEbkt
BioBreak's CEO Forum welcomes human resource execs from @C4Therapeutics, @BeamTx, & @Humacyte to discuss "Talent Management Strategies Post-Pandemic" on June 23 at 5pm ET.
BioBreak membership is required. Register here: lnkd.in/eQFEbkt
Founding sponsor @LocustWalkPtrs
BioBreak retweeted
Looking forward to my first BioBreak tomorrow!
Last chance to register for tomorrow's CBO Forum event from 5-6pm ET. @JebKeiper, CEO of @NimbusTx, & Shakti Narayan, CEO of @accent_tx. will lead the conversation "Managing up to CEOs & Boards".
Register: lnkd.in/eMzBYVM
Thank you to founding sponsor: @LocustWalkPtrs
BioBreak retweeted
Our CEO @JebKeiper is taking part in @BioBreakOrg's CBO Forum this evening to discuss how a CBO can effectively manage up to a CEO and Board of Directors.
BioBreak retweeted
The Biotech Job Market Is As Hot As The Housing Market.
Reflections and advice from Pamela Esposito, CBO of Replimune: The biotech job market is a bit like the suburban housing market—red hot. It’s a buyer’s market, don’t waive your inspection rights!
lifescivc.com/2021/05/the-bi…
BioBreak retweeted
Join us for a live panel discussion, "The Evolving Role of Crossover Financing Rounds," on May 19th at 1:00pm ET. Click here to register: lnkd.in/ePUdwuq
#lifesciences #biotech #biopharma #thoughtleadership #crossover #financings
BioBreak retweeted
Did you miss this week's panel discussion "Should Biotech Bother With Early-Stage Collaborations Given the Hot Financing Market?"
Click here to watch the recording: youtube.com/watch?v=UQ0jNirX…
Thank you to our panelists from @LocustWalkPtrs @EnsomaBio @gritstonebio @AligosThera
BioBreak retweeted
New Panelist! We are excited to announce Lucinda Quan of @AligosThera will be joining us on May 5th at 12pm ET for our panel discussion “Should Biotech Bother With Early-Stage Collaborations Given the Hot Financing Market?"
Click here to register: lnkd.in/erJjViN
BioBreak retweeted
Please join Rachael Bushey for @BioBreakOrg's panel discussion “Current Life Sciences Trends: #IPOs and #SPACs" on Thursday, April 15 at 1 pm ET.
troutman.com/insights/curren…
BioBreak retweeted
Check out @amirahalidrus's @FierceBiotech article on the future of #JPM, featuring quotes from MacDougall’s managing partner, @sharma1: bit.ly/35yIRpD #JPM2021 #JPM21
BioBreak retweeted
Locust Walk is hiring! We are seeking a dynamic General Counsel to join our rapidly growing team. If you are looking to leverage your legal experience with a highly entrepreneurial professional services firm, we’re looking for you! Learn more below.
locustwalk.com/about-us/care…
BioBreak retweeted
We’re here to help you make the most of #JPM21 Week. Don’t forget to utilize MacDougall & @BioCentury 's #JPMGuide to follow #JPM2021 industry news live: bit.ly/3qfdNUK
